Ezra Thevarasalingam

Ezra Thevarasalingam

Associate
Baker & McKenzie LLP

Biography

Ezra is an associate in Baker McKenzie's North American Transactional Practice Group in the Toronto office. He joined the Firm as a summer associate in 2024, completed his articles with the Firm in 2026, and was called to the Ontario Bar in 2026.

Ezra's practice focuses on corporate and securities law matters. During his articles, he assisted on a range of domestic and cross-border transactions, including strategic acquisitions, public offerings, private placements and stock exchange listings. He has a particular interest in capital markets and equity financing transactions.

In law school, Ezra developed a strong interest in business law, securities regulation and corporate transactions. Prior to his legal studies, he attended York University, where he graduated cum laude with an Honours Bachelor of Arts degree.

Practice Focus

Ezra's practice focuses on corporate and securities law matters, including mergers and acquisitions, public and private financing, capital markets transactions and other strategic business matters. He has experience supporting Canadian and international clients, issuers, underwriters and agents on a range of domestic and cross-border transactions, including public offerings, private placements, go-public transactions and complex multi-jurisdictional acquisitions across a variety of industries.

Representative Legal Matters

  • Rosebank Industries PLC's USD 3.05 billion acquisition of two US-based industrial businesses, involving coordination of cross-border workstreams across more than seven jurisdictions.
  • Marimaca Copper Corp.'s CAD 136.5 million Canadian treasury offering of common shares, completed as part of a CAD 409 million global offering, with Beacon Securities Limited and BMO Nesbitt Burns Inc. acting as co-lead agents.
  • Blue Jay Gold Corp.'s CAD 14.7 million brokered private placement of subscription receipts in connection with the company's TSX Venture Exchange listing, with Beacon Securities Limited acting as lead agent.
  • Medicenna Therapeutics Corp.'s CAD 4.44 million marketed public offering of units conducted under its short form base shelf prospectus, with Bloom Burton Securities Inc. acting as sole agent.
  • Conavi Medical Corp.'s CAD 12 million public offering of common shares, including a Canadian prospectus offering and concurrent US private placement, with Bloom Burton Securities Inc. acting as sole and exclusive agent.

Admissions

  • Ontario~Canada (2026)

Education

  • Queen's University (Juris Doctor) (2025)
  • York University (Honours Bachelor of Arts) (2020)

Languages

  • English
  • Tamil
  • Co-author, "Canada: Winds of Change? SCC rejects rigid definition of material change," Baker McKenzie Global Litigation News, 2 March, 2026